Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
The primary hypothesis being tested in this trial is that ischemic stroke patients with active cancer will have improved clinical outcomes when given intravenous thrombolysis compared to standard care.
Phase:
PHASE3
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University